Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0740
-0.0045 (-5.73%)
Oct 16, 2025, 11:01 AM EDT
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $5.83 million as of October 16, 2025. Its market cap has decreased by -47.32% in one year.
Market Cap
5.83M
Enterprise Value
5.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 5.83M, a decrease of -94.61%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 5.83M | -49.71% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | 18.43M | 102.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 367.43M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |